Chronic lymphocytic leukemia at ASH 2017

Por Wanner, David, Steurer, Michael
Publicado no Memo (2018)

Current and evolving treatment strategies in adult immune thrombocytopenia

Por Bohn, Jan-Paul, Steurer, Michael
Publicado no Memo (2018)

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

Por Bohn, Jan-Paul, Gastl, Guenther, Steurer, Michael
Publicado no Memo (2016)

Constitutive Activity among Orphan Class-A G Protein Coupled Receptors

Por Martin, Adam L., Steurer, Michael A., Aronstam, Robert S.
Publicado no PLoS One (2015)

Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation

Por Pircher, Andreas, Gassner, Eva Maria, Steurer, Michael, Wolf, Dominik
Publicado em 2012

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo

Por Kern, Johann, Steurer, Michael, Gastl, Günther, Gunsilius, Eberhard, Untergasser, Gerold
Publicado em 2009

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Por Crazzolara, Roman, Kropshofer, Gabriele, Steurer, Michael, Sopper, Sieghart, Schwinger, Wolfgang
Publicado no J Vis Exp (2017)

Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas

Por Henninger, Benjamin, Steurer, Michael, Plaikner, Michaela, Weiland, Elisabeth, Jaschke, Werner, Kremser, Christian
Publicado no Eur Radiol (2020)

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk

Por Stühlinger, Markus C., Weltermann, Ansgar, Staber, Philipp, Heintel, Daniel, Nösslinger, Thomas, Steurer, Michael
Publicado no Wien Klin Wochenschr (2019)

Low‐dose vemurafenib in hairy cell leukemia patients with active infection

Por Bohn, Jan‐Paul, Pircher, Andreas, Wanner, David, Vill, David, Foeger, Bernhard, Wolf, Dominik, Steurer, Michael
Publicado no Am J Hematol (2019)

Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine

Por Bohn, Jan-Paul, Reinstadler, Vera, Pall, Georg, Stockhammer, Günther, Steurer, Michael, Oberacher, Herbert, Wolf, Dominik
Publicado no Eur J Drug Metab Pharmacokinet (2019)

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry

Por Steurer, Michael, Kern, Johann, Zitt, Matthias, Amberger, Albert, Bauer, Monika, Gastl, Günther, Untergasser, Gerold, Gunsilius, Eberhard
Publicado em 2008

Diagnostic and Therapeutic Challenges of a Large Pleural Inflammatory Myofibroblastic Tumor

Por Loeffler-Ragg, Judith, Bodner, Johannes, Freund, Martin, Steurer, Michael, Uprimny, Christian, Zelger, Bettina, Kähler, Christian M.
Publicado em 2012

Complement factor H-derived short consensus repeat 18–20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells

Por Hörl, Susanne, Banki, Zoltan, Huber, Georg, Ejaz, Asim, Müllauer, Brigitte, Willenbacher, Ella, Steurer, Michael, Stoiber, Heribert
Publicado em 2013

Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient‐reported outcome assessment for the Austrian Myelome R...

Por Sztankay, Monika, Neppl, Lucia, Wintner, Lisa M., Loth, Fanny L., Willenbacher, Wolfgang, Weger, Roman, Weyrer, Walpurga, Steurer, Michael, Rumpold, Gerhard, Holzner, Bernhard
Publicado no Eur J Cancer Care (Engl) (2019)

Akacid Medical Formulation Induces Apoptosis in Myeloid and Lymphatic Leukemic Cell Lines In Vitro and In Vivo

Por Neuwirt, Hannes, Wabnig, Elisabeth, Feistritzer, Clemens, Eder, Iris E., Salvador, Christina, Puhr, Martin, Culig, Zoran, Massoner, Petra, Tiefenthaler, Martin, Steurer, Michael, Konwalinka, Guenther
Publicado no PLoS One (2015)

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Por Cines, Douglas B., Wasser, Jeffrey, Rodeghiero, Francesco, Chong, Beng H., Steurer, Michael, Provan, Drew, Lyons, Roger, Garcia-Chavez, Jaime, Carpenter, Nancy, Wang, Xuena, Eisen, Melissa
Publicado no Haematologica (2017)

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

Por Valent, Peter, Berger, Jörg, Cerny-Reiterer, Sabine, Peter, Barbara, Eisenwort, Gregor, Hoermann, Gregor, Müllauer, Leonhard, Mannhalter, Christine, Steurer, Michael, Bettelheim, Peter, Horny, Hans-Peter, Arock, Michel
Publicado no Ann Hematol (2014)

Platelet gel: a new therapeutic tool with great potential

Por Piccin, Andrea, Di Pierro, Angela M., Canzian, Lucia, Primerano, Marco, Corvetta, Daisy, Negri, Giovanni, Mazzoleni, Guido, Gastl, Günther, Steurer, Michael, Gentilini, Ivo, Eisendle, Klaus, Fontanella, Fabrizio
Publicado no Blood Transfus (2017)

The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event

Por Locher, Maurus, Steurer, Michael, Jukic, Emina, Keller, Markus A., Fresser, Friedrich, Ruepp, Carmen, Wöll, Ewald, Verdorfer, Irmgard, Gastl, Günther, Willenbacher, Wolfgang, Weger, Roman, Nachbaur, David, Wolf, Dominik, Gunsilius, Eberhard, Zschocke, Johannes, Steiner, Normann
Publicado no Am J Hematol (2020)